Author

Meredith Eckstein

Georgetown University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Daniël P. MeltersiD· 1 shared Darrell P. Chandler· 1 shared Élisson Nogueira LopesiD· 1 shared Héjer DhahriiD· 1 shared Jonathan D. LichtiD· 1 shared Kin H. LauiD· 1 shared Kristin V Chesnutt· 1 shared Michael Guy PoirieriD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Daniël P. MeltersORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Aberrant expression of histone H2B variants reshape chromatin and alter oncogenic gene expression programs

Wesley N. Saintilnord, Youssef A. Hegazy, Kristin V Chesnutt, Meredith Eckstein, Richard N Cassidy, Héjer Dhahri, Richard Lynn Bennett, Daniël P. Melters, Élisson Nogueira Lopes, Zhen Fu, Kin H. Lau, Darrell P. Chandler, Michael Guy Poirier, Yamini Dalal, Jonathan D. Licht, Yvonne N. Fondufe‐Mittendorf

This study shows that H2B variants alter chromatin structure and oncogenic gene expression, suggesting they may be early cancer biomarkers and therapeutic targets.

bioRxiv · Nov 18, 2024 · PreprintCancer Biology